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Introduction
More than half of the individuals older than 65 are af-
fected by hypertension. Isolated systolic hypertension, char-
acterized by an increase in systolic arterial pressure without
an increase in diastolic one, is the most frequent type of hy-
pertension in persons over 50 years of age. It occurs de novo
or after a long period of inadequately treated systolic-
diastolic arterial hypertension. The main reason for its oc-
curence is many years mediated increase in stiffness of the
large elastic arteries. This structural change is responsible for
the occurrence of high systolic pressure in the following two
ways: by blood ejection from the left ventricle into the stiff
arterial system of decreased distensibility, and by the in-
crease in the pulse wave velocity with the reflection wave
occurring during late systole. The increased peripheral vas-
cular resistance, sympathetic stimulation and activities of the
Renin Angiotensin Aldosteron (RAA) system play a less sig-
nificant role in the incidence of arterial hypertension in the
elderly than is the case with individuals affected by structural
and functional changes of the aorta.
Previously, vascular stiffness and an increase in systolic
pulse pressure were considered as a part of the aging process
and there was no insistence on treating this type of hyperten-
sion. Nowadays, when it is known that arterial hypertension
in the elderly increases the risk of cardiovascular diseases
three to four times more than in younger persons, it is in-
sisted that this significant risk factor be corrected.
In addition to necessary life style modifications, the ad-
vantage in medical treatment is given to thiazide diuretics
and dihydropiridines from the group of calcium channel
blockers. The therapy should be always adjusted to comor-
bidities.
Elderly persons are defined as individuals at the age of
65 and older. They represent a growing segment of the
population. In 1990, elderly persons comprised 13% of the
total population of the USA and it is estimated that until
2040 they will constitute 20% of the population 
1. As regards
the number of elderly persons, Serbia is ranked as the fourth
country in the world, after Greece, Italy and Japan. Accord-
ing to the data of the Statistical Office of the Republic of
Serbia, approximately 17.24% of the population was elderly
at the end of the last century, and it is estimated that this
number will increase to 30% as far as 2025 
2.
Similarly, the percentage of very old persons (older
than 85) is constantly growing and it is assumed that there
will be 16 million very old persons in the world by the mid-
dle of the 21
st century 
1.
More than half of the individuals over 65 years of age
have hypertension 
1. The principal reason for the increased
incidence of arterial hypertension in the elderly is the grow-
ing number of persons suffering from isolated systolic hy-
pertension (ISH), which is also the most frequent type of hy-
pertension found in this age group 
3, 4. Isolated systolic hy-
pertension is defined as an elevated systolic blood pressure
≥ 140 mmHg with the diastolic pressure value < 90 mmHg.
Much more significant fact than the increased incidence
of the elderly is the fact that the elderly with arterial hyper-
tension, wheter it is isolated systolic or both systolic and dia-
stolic, are at three to four times higher risk to develop car-
diovascular diseases than young individuals. It is an impor-
tant risk factor for stroke, heart failure, coronary artery dis-
ease, terminal renal failure and death 
1.
Epidemiology of arterial hypertension in the elderly
The results of the thirty-year follow-up of patients in-
cluded in the Framingham Heart Study have shown that
systolic blood pressure (SBP) continually increases from the
age of 30 to 84. Unlike systolic blood pressure, diastolic
blood pressure (DBP) increases until the fifth decade andStrana 780 VOJNOSANITETSKI PREGLED Volumen 68, Broj 9
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then gradually decreases through the age of 60. This results
in the increase of pulse pressure (PP) 
5, which is ilustrated in
Figures 1 and 2.
As it is already mentioned ISH is the predominant type
of arterial hypertension among individuals older than fifty.
ISH is present in 8% to 15% of all individuals over 60 years
of age 
6. The third National Health and Nutrition Examina-
tion Survey (NHANES III) has shown that more than 80% of
persons over 50 who suffer from arterial hypertension have
systolic hypertension (Figure 3) 
7. Its incidence progressively
increases with age by 5%, 15%, and 25%, in the sixth, sev-
enth and eighth decade, respectively 
6.
Despite the general pattern of arterial blood pressure
changes are similar for both genders, the arterial pressure,
which is lower in women younger than 50, gradually in-
creases from that age and results in values significantly
higher than in men over sixty 
8. This phenomenon is a con-
sequence of menopause, which enhances the age-induced in-
crease of arterial blood pressure.
Structural changes of large arteries in elderly persons
and the reasons of their occurrence
The age-associated increase in stiffness of large arteries
is the main characteristic of arterial hypertension in the eld-
erly 
2. Structural changes affect the aorta and elastic arteries,
whereas the structure of muscular arteries does not change
significantly. Elastic arteries undergo thickening of the tu-
nica intima and their tunica media loses the ordered structure
of elastic fibre and lamina that become thinner due to rup-
tures and fragmentation. Levels of collagen and matrix pro-
tein rise. Calcium binds to elastin and the undifferentiated
muscle cells of the tunica media that proliferate and migrate
into the intima. Proliferation of connective tissue results in
the thickening of the intima and media fibrosis, along with
the loss of distensibility and partial loss of its contractility.
A logical explanation for these alterations lies in the
fact that the stress cycle accumulated in six decades as a re-
sult of more than two billion expansions of the aorta in the
course of ventricular contraction leads to fatigue of the mate-
rial and consequential structural changes 
9, 10.
Genetic polymorphism also plays a role in the process of
cardiovascular aging 
11. A combination of two or three poly-
morphisms may influence the characteristics of the vascular
wall much more consistently than a single polymorphism. In
elderly persons suffering from ISH, the DD genotype of an-
giotensin-converting enzyme gene polymorphism, combined
with the specific genotype of aldosterone synthetase and α-
adducin gene polymorphism influence the reduction of arterial
compliance and distensibility, which in turn are responsible for
the incidence of ISH and augmentation of PP.
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Fig. 1 – Mean systolic and diastolic blood pressures by age
for men in the US population, 18 years of age and older 
5
Fig. 2 – Mean systolic and diastolic blood pressures by age
for women in the US population, 18 years of age and older 
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Fig. 3 – Categories of blood pressure in untreated hypertensive patients illustrating the importance of
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The age-induced structural changes in large arteries oc-
cur independently of other risk factors, but the role of hyper-
cholesterolemia, smoking, insulin resistance, etc. cannot be
ignored in the development of endothelial dysfunction, and
thereby the development of arterial hypertension. On the
other hand, high systolic blood pressure increases wall stress
that causes the damage of endothelium, which, in a vicious
circle, maintains high levels of arterial blood pressure.
Pathophysiology of arterial hypertension in elderly
persons
The value of systolic blood pressure (SBP) is a result of
the interaction among the following three factors: character-
istics of left ventricular ejection, and compliance of large ar-
teries, and propagative and reflective properties of the pulse
wave in the arterial tree.
As noted above, the dominant reason for the increased
SBP in the elderly with ISH is an increased stiffness of the
arteries, which produces negative effects in two ways –
through direct and indirect mechanisms 
12, 13. The direct
mechanism involves the creation of high systolic pressure by
the ejection of blood from the left ventricle into the stiff arte-
rial system of decreased distensibility. The indirect mecha-
nism implies the influence that the arterial stiffness has on
the velocity of pulse wave and on the pressure wave reflec-
tion time. With the increase of arterial stiffness and the ve-
locity of the pulse wave, the reflection wave returns into the
central artery earlier, usually during late systole and less of-
ten during early diastole. This causes increase in the aortic
and left ventricular pressure during systole and a reduction
aortic pressure during diastole 
14. This is shown in Figure 4.
Fig. 4 – With aging large arteries stiffen, and the reflected
wave, which travels faster, is superimposed over the forward
wave in early systole, increasing both systolic and pulse
pressure
In our research, published ten years ago, we found that
aortic distensibility estimated by echocardiography inversely
correlated with pulse wave velocity in patients with isolated
systolic hypertension older than 65 
15.
One of the characteristics of arterial hypertension in the
elderly is an increase in the activity of the sympathetic nerv-
ous system which leads to down-regulation of adrenergic re-
ceptors 
16. On the other hand, beta-adrenergic receptor sensi-
tivity is diminished, which reflects in a decreased chrono-
tropic response to beta antagonists and indicates a lesser sig-
nificance of sympathetic stimulation in the development of
arterial hypertension and less efficiency in treatment with
beta blockers in elderly individuals.
Another mechanism contributing to the development
of arterial hypertension in the elderly is endothelial dys-
function
 17. It is manifested in decreased nitric oxide-
mediated dilatation. Taking the increase in aortic pulse wave
velocity as the measure of stiffness of large arteries, Wallace
et al. 
18 have shown that it correlates with endothelial dys-
function.
Additionally, the number of nephrons decreases with
age and a total of 800,000 nephrons at birth reduces by half
at the age of 70 
19. The nephrosclerosis developed as a result
of aging and arterial hypertension leads to the decreased se-
cretion of renin from the kidneys. Thus, in elderly with arte-
rial hypertension we usually find decreased levels of renin in
circulation and lower plasma renin activity. Low levels of
renin can also occur as a result of the salt retention tendency
with consequential volume load, which leads to increase of
arterial pressure and suppression of renin release from the
juxtaglomerular cells. This characteristic of the arterial hy-
pertension in elderly persons explains better responsiveness
of arterial hypertension to the application of diuretics and
calcium channel blockers, and its lower responsiveness to the
treatment with ACE inhibitors, AT1-receptor blockers and
beta blockers.
Elderly hypertensive persons, as well as the normoten-
sive ones, show salt sensitivity, which is indirectly proven by
significant decrease of blood pressure values with the loss of
salt or reduction of salt intake 
13, 20.
Elderly persons who suffered from arterial hypertension
at younger age and sustained it at old age show a more sig-
nificant increase in peripheral vascular resistance than those
whose aging was the reason for the occurrence of arterial hy-
pertension.
Hemodynamically, ISH is characterised by a decrease
in cardiac output, stroke volume and intravascular volume 
10.
Baroreceptor sensitivity to changes in blood pressure levels
is decreased, which results in significant variations of the
arterial blood pressure values.
Specific characteristics of arterial hypertension in the
elderly
Diagnosing arterial hypertension in the elderly, espe-
cially very old ones, may be accompanied with problems. In
approximately 2% to 5% of elderly persons with rigid, calci-
fied arteries, it is impossible to ensure the collapse of the
brachial artery, which gives false high values of the arterial
blood pressure 
21. This phenomenon is called pseudohyper-
tension. Pseudohypertension is suspected in persons with
minimal vascular damage of the retina in spite of the high
measured values of arterial blood pressure, and in those who
show postural symptoms after discontinuation of therapy.
Arterial hypertension in the elderly is characterised by
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which can be proved by 24-hour ambulatory blood pressure
monitoring. In one of our researches we found that variations
of systolic pressure values in hypertensive subjects older
than 60 years correlated with their age and they were the
most frequent in patients older than 80 years of age. We also
determined that reduction of systolic blood pressure during
night inversely correlated with age 
22. However, significant
individual variations of systolic arterial pressure in elderly
persons during the night indicate the risk of brain stroke. The
risk of cardiovascular events is also increased during the
early morning increase in the values of arterial pressure 
13.
The white coat hypertension was detected in 24% of elderly
persons. In one of our investigations we found that the
prevalence of the white coat hypertension was higher in the
elderly with isolated systolic hypertension than in patients
with combined systolic and diastolic hypertension which
were the same age 
23. Another phenomenon that may be seen
in the elderly is the phenomenon of reverse white coat hy-
pertension, which implies that the values obtained during 24-
hour monitoring of arterial pressure are higher than those
obtained through conventional measuring in the doctor’s of-
fice.
Moreover, another phenomenon characteristic of the
elderly population is ortostatic hypotension, which is defined
as a fall in SAP by at least 20 mmHg and a fall in diastolic
pressure by 10 mmHg within three minutes after getting up.
The main reasons for its occurrence are the decrease in baro-
receptor sensitivity and the deficit of heart-rate response to
the change in body position. The incidence of occurrence of
ortostatic hypotension increases from 17% in persons 65 to
74 years of age to 26% in persons older than 85. Ortostatic
hypotension poses the risk of traumatism, and, on the other
hand, it is a risk factor for cardiovascular diseases. Likewise,
ortostatic hypotension increases the risk of brain stroke and
dementia 
24.
Reduction of arterial blood pressure may also occur af-
ter eating, which is referred to as postprandial hypotension 
13.
The basic reason for its occurrence is an inadequate response
to vasodilatory effects of gastrointestinal peptides and insu-
lin. It has been established that approximately 70% of indi-
viduals older than 70 show fall in arterial pressure values af-
ter meals, and that in 24% of the cases reduction is over 16
mmHg for systolic and over 12 mmHg for diastolic arterial
pressure. Not a small number of the elderly have a weakness,
even syncope after breakfast which, besides all the possible
metabolic reasons, can be also explained with the postpran-
dial hypotension that is easily detected by the 24-hour blood
pressure monitoring. However, if the evidence of postpran-
dial hypotension is missing then the 24-hour blood pressure
monitoring should be repeated at least twice if there are no
conditions for hospitalization.
The implications of high pulse pressure
This caracteristics of arterial hypertension in the elderly
complicate the treatment of these patients. Yet, they cannot
be a barrier to the medical treatment, which is extremely im-
portant due to the subclinical and clinical consequences of
arterial hypertension in elderly persons. The left ventricle
becomes stiff, in addition to the stiffness of the large ar-
teries 
12. Moreover, left ventricle hypertrophy is often
found in the elderly suffering from ISH. In our examination
of the influence of the aortic distensibility on systolic and
pulse pressure in patients with isolated systolic hypertension,
we found that the patients with this form of arterial hyperten-
sion in addition to impaired left ventricular relaxation also
have concentric remodeling pattern of left ventricle as domi-
nant pattern 
15. Stiffness of the left ventricle combined with
decreased distensibility of the arterial system increases the
risk of cardiovascular diseases in several ways. Among other
problems, the wall stress increases, which in turn enlarges
the energy necessary for cardiac cicle. The increase in left
ventricular stress during late systole leads to incomplete dia-
stolic relaxation, and eventually to heart failure with pre-
served ejection fraction.
Isolated systolic hypertension is often combined with
coronary artery disease, thrombotic and hemorrhagic strokes,
dementia, peripheral arterial disease and slow progressing
heart and renal failure 
25. Comparing the results of normoten-
sive elderly persons with the elderly suffering from ISH it
has been shown that the increase of systolic blood pressure
by 1 mmHg raises the incidence of coronary artery disease,
stroke and overall mortality by 1%. This finding is real evi-
dence for the significance and severity of this type of arterial
hypertension.
Treatment of arterial hypertension in the elderly
The purpose of treating arterial hypertension in elderly
persons is identical to the purpose of treating it in young and
middle-aged populations – its reduction to values below
140/90 mmHg, ie reduction to values below 130/80 mmHg
in the high-risk patients with clinical damage (after acute
myocardial infarction, due to renal failure, after cerebrovas-
cular insult) and those suffering from diabetes mellitus 
26.
Like in the case with hypertensive patients in younger age,
reduction of body weight, restriction of salt intake according
to DASH (Dietary Approaches to Stop Hypertension), in-
creased physical activity and moderate alcohol intake (one
serving per day for women and two servings for men) is ad-
vised for the elderly regardless of the type of arterial hyper-
tension 
24.
According to our experience an essential precondition
to achieve the target values of arterial blood pressure in pa-
tients older than 65, and especially older than 70 years of
age, is the reduction in salt intake of 100 mmoL/day (ie 4.7
to 5.8 g NaCl). This can be explained by the above-
mentioned salt sensitivity which increases through the life-
time. One of the problems in the modification of a lifestyle is
the changes in the bones and joints, which restrict mobility
and require a combined medical approach including physio-
therapist who will show these patients some exercises that
are crucial for maintaining and prevention of the reduction of
large arteries distensibility as well as for the sustenance of a
desired weight and the decline of body overweight.
In drug treatment, there are five available large groups
of antihypertensives: thiazide diuretics, calcium channel
blockers, angiotensin–converting enzyme (ACE) inhibitors,Volumen 68, Broj 9 VOJNOSANITETSKI PREGLED Strana 783
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angiotensin (AT)1-receptor blockers, and beta blockers. Each
of these groups reduces the values of arterial blood pressure in
a similar way, thus reducing the incidence of cardiovascular
events. Different clinical trials have shown that medicament
treatment of these patients reduced the risk of cerebrovascular
insult, coronary artery disease, acute myocardial infarction,
mortality of coronary artery disease and total mortality (Tables
1 and 2). The specificity of treating elderly persons is in intro-
ducing smaller dosage of the drugs due to the significant oc-
currence of adverse effects in this population.
The initial randomized controlled studies showed the
benefit from the use of diuretics or beta blockers compared
with placebo in the treatment of various forms of arterial hy-
pertension in the elderly 
27–30. However, Masserli et al. 
31
using meta-analysis showed that beta blockers used in the
treatment of arterial hypertension in the elderly were less ef-
fective than diuretics in the prevention of cardiovascular
events. Based on the results of large randomized studies
(SHEP and Syst-Eur) thiazide diuretics and calcium channel
blockers (especially dihydropiridines) were suggested as the
first-line therapy in the treatment of ISH 
32, 33. The studies
that followed examined the advantage of the "new" (new
generation dihydropiridines, ACE inhibitors and AT1 re-
ceptor blockers) in relation to the "old" (beta blockers and
thiazide diuretics) antihypertensives. The ALLHAT study
showed that thiazide diuretic, ACE inhibitor and calcium
channel blocker reduced the frequency of cardiovascular
events in the subgroup of patients older than 65 years of age
equally well 
34. The LIFE study showed that the AT1 recep-
tor blocker was more effective than beta blocker in the pre-
vention of cardiovascular events, especially cerebrovascular
insult in hypertensive patients aged 55 to 80 with left ventri-
cle hypertrophy 
35. The advantage of AT1 receptor blockers
in the prevention of the nonfatal cerebral stroke in patients
older than 70 years of age with ISH was confirmed by the re-
sults of SCOPE study 
36.
Last year the results of the HYVET study which dem-
onstrated the benefit of treatment of very old hypertensive
patients (older than 80) were published. It was shown that
the use of indapamide with or without perindopril in this
population of patients led to a reduction of death counts from
cerebral stroke, heart failure and total mortality. This elimi-
nated the suspicion about necessity of treatment of very old
hypertensive patients 
37.
As it can be concluded from the above-mentioned, the
large randomized studies have shown the benefit from the
Table 1
Clinical trials of different antihypertensive drugs in the elderly
Clinical trial Population Treatment
STOP-Hyper 
27
Age, 70–84 years
SBP ≥ 180 mmHg and/or
DBP ≥ 105 mmHg
Metoprolol/ atenolol/ pindolol or
hydrochlorthiazide/amiloride vs placebo
SHEP 
32
Age ≥ 60 years
SBP ≥ 160 mmHg and
DBP < 90 mmHg
Chlorthalidone or amiloride vs placebo
Syst-Eur 
33
Age ≥ 60 years
SBP ≥ 160 mmHg and
DBP < 95 mmHg
Nitrendipine, enalapril and hydrochlorthiazide vs placebo
MRC 
28 Age, 65–74 years
SBP ≥ 160 mmHg Amiloride + hydrochlorthiazide or atenolol vs placebo
HYVET 
37
Age ≥ 80 years
SBP ≥ 160 mmHg
and
DBP > 90 mmHg
Indapamide SR + perindopril vs placebo
LIFE 
35 Mean age 67
Hypertension with LVH Losartan vs atenolol
Stop-Hyper – Swedish Trial in Old Patients with Hypertension; SHEP – Systolic Hypertension in the Elderly Program; Syst-Eur – Systolic
Hypertension-Europe; MRC – Medical Research Council trial of treatment of hypertension in older adults; HYVET – Hypertension in the Very
Elderly Trial; LIFE – Losartan Intervention for Endpoint reduction in hypertension; SBP – systolic blood pressure; DBP – diastolic blood
pressure; LVH – left ventricle hypertrophy
Table 2
The most important outcomes of clinical trials
Trial Stroke CAD AIM CAD mortality Total mortality
STOP-Hyper -47% -13% -40% NS -43%
SHEP -36% -27% -32% -20% -13%
Syst-Eur -42% -26% -31% -27% -14%
MRC -25% -19% -17% -9% -3%
HYVET -30% / / -23% -21%
LIFE -40% / -11% -46% -28%
Stop-Hyper – Swedish Trial in Old Patients with Hypertension; SHEP – Systolic Hypertension in the Elderly Program; Syst-
Eur – Systolic Hypertension-Europe; MRC – Medical Research Council trial of treatment of hypertension in older adults;
HYVET – Hypertension in the Very Elderly Trial; LIFE – Losartan Intervention for Endpoint reduction in hypertension;
CAD – coronary artery disease; AIM – acute myocardial infarction; NS – statistically non-significant; / – not determinatedStrana 784 VOJNOSANITETSKI PREGLED Volumen 68, Broj 9
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applying of all groups of antihypertensives in treatment of
old hypertensive patients. However, in everyday practice we
face the dilemma about which medication to use first. The
basic thing in these circumstances is the information about
the associated risk factors and the information about sub-
clinical and clinical manifestations of target organs damage.
Undoubtedly, in patients with ISH without associated risk
factors and organs damage we will apply thiazide diuretics
with or without calcium channel blockers (Table 3). In other
conditions, when elderly patients have associated diabetes
mellitus or heart failure, and after acute myocardial infarction
ACE inhibitors or AT1 receptor blockers have priority, as well
as in younger or middle-aged patients. In older hypertensive
subjects with proved coronary artery disease beta blocker will
be applied regardless the results of study which showed a little
benefit from their usage in the prevention of cardiovascular
events (not only because of well-known advantages of this
class of drugs in the coronary heart disease but also because
the study included only patients without coexisting coronary
heart disease). Similarly, in the old hypertensive patients with
vascular hypertrophy (changes in intima-media thickness of
carotid artery) we should try to regulate arterial hypertension
using metabolic neutral drugs with antiatherogenic potential
(ACE inhibitors, AT1 receptors blockers or calcium channel
blockers). It means that the decision about antihypertensives
we will prescribe in the elderly depends on a comprehensive
assessment of each patient individually.
One of the problems in the treatment of arterial hyper-
tension in the elderly is that the majority of patients with ISH
have difficulty to achieve and maintain the reduction of arte-
rial blood pressure to the target value using monotherapy,
because a combined therapy is required. In these situations
we apply the same principles of drug selection as previously
mentioned. Nevertheless, a number of patients apart from
taking three antihypertensives (thiazide diuretic is one of
them) do not have optimal regulation of arterial pressure. If
arterial hypertension exists in spite of compliance of pro-
posed lifestyle changes and advised polytherapy, after ex-
cluding secondary forms of arterial hypertension (stenosis of
renal artery usually of atherosclerotic nature), we can con-
clude that it is a resistant arterial hypertension in question.
The reason for resistant arterial hypertension in the elderly
are the structural changes of large arterial blood vessels. In
these circumstances, we use different modifications of a
medical treatment to achieve a regular blood pressure, which
is sometimes impossible.
Additionally, there is one more problem in treatment of
the elderly. Namely, it is difficult to maintain optimal values
of diastolic arterial pressure in these subjects with ISH. Pro-
tegerou et al. 
38 have shown that the values of diastolic pres-
sure ≤ 60 mmHg reduce survival despite of the stiffness of
large arteries and the function of the left ventricle 
38. They
have suggested that it requires optimization of therapy not
only regarding the values of systolic, but also diastolic arte-
rial pressure.
In these circumstances where we have a significant re-
duction of diastolic pressure value (≤ 60 mmHg) in patients
with ISH we are satisfied with accomplished but not optimal
regulation of systolic blood pressure, like in the resistant ar-
terial hypertension.
Conclusion
From all the abovementioned we can conclude that
there is no dilemma whether the treatment of arterial hyper-
tension of the elderly is necessary. Furthermore, it should be
adapted to each patient and the success of the treatment is
not always guaranteed.
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